These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33925829)

  • 1. Antihypertensive Drug Use and the Risk of Ovarian Cancer Death among Finnish Ovarian Cancer Patients-A Nationwide Cohort Study.
    Santala EEE; Artama M; Pukkala E; Visvanathan K; Staff S; Murtola TJ
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive drugs and prostate cancer survival after radical prostatectomy in Finland-A nationwide cohort study.
    Santala EE; Rannikko A; Murtola TJ
    Int J Cancer; 2019 Feb; 144(3):440-447. PubMed ID: 30110124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
    Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
    BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of urothelial cancer death among people using antihypertensive drugs-a cohort study from Finland.
    Santala EEE; Kotsar A; Veitonmäki T; Tammela TLJ; Murtola TJ
    Scand J Urol; 2019 Aug; 53(4):185-192. PubMed ID: 31250699
    [No Abstract]   [Full Text] [Related]  

  • 5. Antihypertensive drug use and prostate cancer-specific mortality in Finnish men.
    Siltari A; Murtola TJ; Talala K; Taari K; Tammela TLJ; Auvinen A
    PLoS One; 2020; 15(6):e0234269. PubMed ID: 32598349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).
    Ruiz de Sabando A; Urrutia Lafuente E; García-Amigot F; Alonso Sánchez A; Morales Garofalo L; Moreno S; Ardanaz E; Ramos-Arroyo MA
    BMC Cancer; 2019 Nov; 19(1):1145. PubMed ID: 31771539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing risks of death in younger and older postmenopausal breast cancer patients.
    Chapman JA; Pritchard KI; Goss PE; Ingle JN; Muss HB; Dent SF; Vandenberg TA; Findlay B; Gelmon KA; Wilson CF; Shepherd LE; Pollak MN
    World J Clin Oncol; 2014 Dec; 5(5):1088-96. PubMed ID: 25493245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual fertility assessment and counselling in women of reproductive age.
    Petersen KB
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer.
    Ye Y; Dai Q; Qi H
    Cell Death Discov; 2021 Apr; 7(1):71. PubMed ID: 33828074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension after heart transplantation].
    Simonenko MA; Fedotov PA; Sazonova YV; Bortsova MA; Sitnikova MY; Karpenko MA; Belyaeva NN; Nikolaev GV; Gordeev ML
    Kardiologiia; 2020 Jul; 60(6):880. PubMed ID: 32720616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer.
    Gao Y; Liu X; Li T; Wei L; Yang A; Lu Y; Zhang J; Li L; Wang S; Yin F
    Oncol Rep; 2017 May; 37(5):3084-3092. PubMed ID: 28350120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects on mortality of the use of combined oral contraceptives.
    Oldfield K; Milne R; Vessey M
    Br J Fam Plann; 1998 Apr; 24(1):2-6. PubMed ID: 9719700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer.
    Tian X; Han Y; Yu L; Luo B; Hu Z; Li X; Yang Z; Wang X; Huang W; Wang H; Zhang Q; Ma D
    Cancer Biol Ther; 2017 Apr; 18(4):245-251. PubMed ID: 28346042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning and bioinformatics models to identify gene expression patterns of ovarian cancer associated with disease progression and mortality.
    Hossain MA; Saiful Islam SM; Quinn JMW; Huq F; Moni MA
    J Biomed Inform; 2019 Dec; 100():103313. PubMed ID: 31655274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters.
    Sartor H; Bjurberg M; Asp M; Kahn A; Brändstedt J; Kannisto P; Jirström K
    J Ovarian Res; 2020 Mar; 13(1):26. PubMed ID: 32145749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Risks for Ovarian, Endometrial, Breast, Colorectal, and Other Cancers in Women With Newly Diagnosed Endometriosis or Adenomyosis: A Population-Based Study.
    Kok VC; Tsai HJ; Su CF; Lee CK
    Int J Gynecol Cancer; 2015 Jul; 25(6):968-76. PubMed ID: 25893280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.